Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study

EuroIntervention

25 Maggio Mag 2018 2 months ago
  • Fabbiocchi F

Polymer-free biolimus-eluting stents (PF-BES) have been shown superior to bare metal stents in high bleeding risk (HBR) patients treated with 1-month dual antiplatelet therapy (DAPT). However, limited evidence is available on PF-BES in non-HBR patients. We aim to evaluate the safety and efficacy of PF-BES in all-comer patients undergoing percutaneous coronary interventions (PCI).

Refernce

Sardella G, Stefanini GG, Briguori C, Tamburino C, Fabbiocchi F, Rotolo F, Tomai F, Paggi A, Lombardi M, Gioffrè G, Sclafani R, Rolandi A, Sciahbasi A, Scardaci F, Signore N, Calcagno S, Mancone M, Chiarito M, Giordano A. Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. EuroIntervention 2018 May 21. pii: EIJ-D-18-00148. doi: 10.4244/EIJ-D-18-00148. [Epub ahead of print]

Go to PubMed